Interpreting Patient-Reported Outcome Scores: Pediatric Inflammatory Bowel Disease as a Use Case

Julia Schuchard1, Adam C Carle2, Michael D Kappelman3

  • 1Department of Pediatrics, Children's Hospital of Philadelphia (J Schuchard and CB Forrest), Philadelphia, Pa.

Academic Pediatrics
|January 7, 2022
PubMed

Insights

This study provides methods to interpret Patient-Reported Outcomes Measurement Information System (PROMIS) scores for pediatric inflammatory bowel disease (IBD) patients. It establishes IBD-specific percentiles and minimal clinically important differences for better score interpretation.

Area of Science:

  • Pediatric gastroenterology
  • Clinical trial methodology
  • Health outcomes research

Background:

  • Interpreting patient-reported outcome measure (PROM) scores in pediatric inflammatory bowel disease (IBD) is crucial for clinical decision-making.
  • Existing interpretation methods may not adequately capture the nuances of health in pediatric IBD populations.

Purpose of the Study:

  • To establish disease-specific percentiles and minimal clinically important difference (MCID) thresholds for 6 pediatric PROMIS measures in patients with IBD.
  • To demonstrate the application of these interpretation tools using data from a clinical trial.

Main Methods:

  • A prospective cohort study of 1049 patients (ages 8-23) with IBD was used to establish IBD-specific percentiles and MCID for 6 PROMIS measures.
  • These measures, along with general population percentiles and reliable change index, were applied to interpret PROM scores in a clinical trial sample (n=294, ages 8-20) at baseline and 3 months.

Main Results:

  • At baseline, the clinical trial sample reported worse health than the general population (e.g., 22% above 95th percentile for Fatigue).
  • Compared to a reference IBD sample, the clinical trial sample showed slightly worse scores (e.g., 8% above 95th percentile for Fatigue).
  • MCID application showed that among patients with improved Pediatric Crohn's Disease Activity Index scores, significant proportions also improved in IBD Symptoms (45%), Fatigue (47%), and Pain Interference (65%).

Conclusions:

  • This study successfully established IBD-specific percentiles for 6 pediatric PROMIS measures.
  • The findings demonstrate the utility of these percentiles and MCID for interpreting PROM scores in pediatric IBD clinical trials.
  • These tools enhance the understanding of patient-reported outcomes in this population.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
448
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
228
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
441
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
245
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
267
Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
326